Kristie Ann Wagner - 24 Feb 2022 Form 4 Insider Report for Entasis Therapeutics Holdings Inc.

Role
VP, Principal Fin & Acct Off
Signature
Elizabeth M. Keiley as Attorney-in-Fact for Kristie Wagner
Issuer symbol
N/A
Transactions as of
24 Feb 2022
Net transactions value
$0
Form type
4
Filing time
25 Feb 2022, 15:30:59 UTC
Next filing
11 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETTX Common Stock Award $0 +10,000 +14% $0.000000 80,500 24 Feb 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This award vests in equal 1/4 increments over four years on the anniversary of the date of grant, subject to the reporting person's continued employment with the company.